Related Experiment Videos

The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized

Jane M Garbutt1, Bridget Conlon, Randall Sterkel

  • 11Washington University in St. Louis, St. Louis, MO, USA.

Clinical Pediatrics
|October 5, 2013
PubMed

Insights

This study found no significant differences in outcomes for children treated with prednisolone versus dexamethasone for croup. Both treatments were equally effective in managing croup symptoms and parental stress.

Area of Science:

  • Pediatrics
  • Pharmacology

Background:

  • Limited evidence supports the use of prednisolone for treating croup.
  • Croup is a common respiratory condition in children.

Purpose of the Study:

  • To compare the effectiveness of prednisolone versus dexamethasone in treating croup in children.
  • To evaluate additional healthcare utilization, symptom duration, and parental stress between treatment groups.

Main Methods:

  • A community-based randomized trial involving children aged 1-8 years with croup symptoms.
  • Comparison of prednisolone (2 mg/kg/d for 3 days) against a single dose of dexamethasone (0.6 mg/kg).
  • Outcomes assessed included additional healthcare needs, symptom duration, cough, sleep disturbance, and parental stress.

Main Results:

  • No statistically significant differences were observed between prednisolone and dexamethasone groups for additional healthcare utilization (2% vs 7%, P = .34).
  • Duration of croup symptoms (2.8 vs 2.2 days, P = .63) and non-barky cough (6.1 vs 5.9 days, P = .81) showed no significant variation.
  • Parental outcomes, including nights with disturbed sleep (0.68 vs 1.21 nights, P = .55) and days with stress (1.39 vs 1.56 days, P = .51), were similar between the groups.

Conclusions:

  • Prednisolone and dexamethasone demonstrate comparable effectiveness in treating pediatric croup.
  • No significant differences in child or parent outcomes were detected between the two treatment regimens.

Keywords:
croupdexamethasoneprednisolonerandomized trial

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...